Abstract
Introduction: The goal of the present study was to develop a short version (SV) of the Quality of Life Relevance-Acne (QOLRELEVANCE-ACNE) based on the identified most relevant items for acne patients. Methods: Members of the international internet group for acne patients were asked to fill in the short prototype version of the QOLRELEVANCE-ACNE. Internal consistency was measured using Cronbach’s alpha. Results: The answers of 684 acne patients were collected. The analysis revealed that the internal consistency of the instrument could be improved by removing a single item. That item was removed and the final four-item short version of the QOLRELEVANCE-ACNE-SV was formed. There is minimal or no overlapping of the QOLRELEVANCE-ACNE-SV with other brief forms of acne-specific HRQoL instruments. Conclusion: The four-item QOLRELEVANCE-ACNE-SV questionnaire was developed and showed good internal consistency. An international validation study of the QOLRELEVANCE-ACNE-SV will be performed.
Journal Section:
Brief Report
References
1.
Nast
A
, Dréno
B
, Bettoli
V
, Bukvic Mokos
Z
, Degitz
K
, Dressler
C
, et al. European evidence-based (S3) guideline for the treatment of acne-update 2016-short version
. J Eur Acad Dermatol Venereol
. 2016
;30
(8
):1261
–8
. 2.
Chernyshov
PV
, Zouboulis
CC
, Tomas-Aragones
L
, Jemec
GB
, Manolache
L
, Tzellos
T
, et al. Quality of life measurement in acne. Position paper of the European Academy of dermatology and Venereology task Forces on quality of life and patient oriented outcomes and acne, Rosacea and hidradenitis Suppurativa
. J Eur Acad Dermatol Venereol
. 2018
;32
(2
):194
–208
. 3.
Marron
SE
, Chernyshov
PV
, Tomas-Aragones
L
. Quality-of-Life research in acne vulgaris: current status and future directions
. Am J Clin Dermatol
. 2019
;20
(4
):527
–38
. 4.
Chernyshov
PV
, Sampogna
F
, Zouboulis
CC
, Boffa
MJ
, Marron
SE
, Manolache
L
, et al. Which health-related quality of life items most affect acne patients
. Dermatology
. 2023
;239
(2
):267
–72
. 5.
Chernyshov
PV
, Sampogna
F
, Raimondi
G
, Zouboulis
CC
, Boffa
MJ
, Marron
SE
, et al. Development of the acne-specific quality of life questionnaire Quality of Life Relevance-Acne
. JAAD Int
. 2024
;16
:9
–17
. 6.
Chernyshov
PV
. The evolution of quality of life assessment and use in dermatology
. Dermatology
. 2019
;235
(3
):167
–74
. 7.
Wessa
P
. Cronbach alpha (v1.0.7) in free statistics software (v1.2.1), office for research development and education
. 2023
. Available from: https://www.wessa.net/rwasp_cronbach.wasp/8.
Motley
RJ
, Finlay
AY
. Practical use of a disability index in the routine management of acne
. Clin Exp Dermatol
. 1992
;17
(1
):1
–3
. 9.
Tan
J
, Fung
KY
, Khan
S
. Condensation and validation of a 4-item index of the Acne-QoL
. Qual Life Res
. 2006
;15
(7
):1203
–10
. 10.
McLellan
C
, Frey
MP
, Thiboutot
D
, Layton
A
, Chren
MM
, Tan
J
. Development of a comprehensive quality-of-life measure for facial and torso acne
. J Cutan Med Surg
. 2018
;22
(3
):304
–11
. 11.
Finlay
AY
. Broader concepts of quality of life measurement, encompassing validation
. J Eur Acad Dermatol Venereol
. 2017
;31
(8
):1254
–9
. 12.
Misery
L
, Belloni Fortina
A
, El Hachem
M
, Chernyshov
P
, von Kobyletzki
L
, Heratizadeh
A
, et al. A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task force
. J Eur Acad Dermatol Venereol
. 2021
;35
(4
):787
–96
. 13.
Chernyshov
PV
, Boffa
MJ
, Corso
R
, Pustišek
N
, Marinovic
B
, Manolache
L
, et al. Creation and pilot test results of the dermatology-specific proxy instrument: the Infants and Toddlers Dermatology Quality of Life
. J Eur Acad Dermatol Venereol
. 2018
;32
(12
):2288
–94
. 14.
Chernyshov
PV
, Suru
A
, Gedeon
I
, Derevyanko
LA
, Tiplica
GS
, Salavastru
CM
. Epidermolysis bullosa-specific module of the infants and toddlers dermatology quality of life (InToDermQoL) questionnaire
. J Eur Acad Dermatol Venereol
. 2019
;33
(3
):612
–7
. 15.
Chernyshov
PV
, Sampogna
F
, Pustišek
N
, Marinovic
B
, Manolache
L
, Suru
A
, et al. Validation of the dermatology-specific proxy instrument the infants and toddlers dermatology quality of life
. J Eur Acad Dermatol Venereol
. 2019
;33
(7
):1405
–11
. 16.
Chernyshov
PV
, Finlay
AY
, Tomas-Aragones
L
, Poot
F
, Sampogna
F
, Marron
SE
, et al. Quality of life in hidradenitis Suppurativa: an update
. Int J Environ Res Public Health
. 2021
;18
(11
):6131
. 17.
Chernyshov
PV
, Jiráková
A
, Hercogová
J
. Comparative study of the quality of life of children with atopic dermatitis from Ukraine and the Czech Republic
. J Eur Acad Dermatol Venereol
. 2011
;25
(12
):1483
–4
. 18.
Chernyshov
PV
. Health-related quality of life in adult atopic dermatitis and psoriatic patients matched by disease severity
. G Ital Dermatol Venereol
. 2016
;151
(1
):37
–43
.19.
Chernyshov
PV
. May the gender of a parent influence assessment of health-related quality of life, family impact and severity of atopic dermatitis in children
. Pediatr Dermatol
. 2009
;26
(1
):99
–100
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
